CXSL2400221 | QL2108注射液 | QL-2108 | Injection | Biological Products(3.3) | New Drug Application | 2024-04-10 | | QILU Pharmaceutical Co Ltd | | | view |
CXSB2500066 | QL2108注射液 | QL-2108 | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |
CXSB2500065 | QL2108注射液 | QL-2108 | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |
CXSB2500063 | QL2108注射液 | QL-2108 | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |
CXSB2500064 | QL2108注射液 | QL-2108 | Injection | Biological Products | Supplementary Application | 2025-05-14 | | QILU Pharmaceutical Co Ltd | | | view |